What is Champions Oncology, Inc.'s Market Cap?

Champions Oncology, Inc.'s Market Cap is $65.7M, based on as-reported figures from SEC (XBRL) filings.

What is Champions Oncology, Inc.'s Enterprise Value?

Champions Oncology, Inc.'s Enterprise Value is $61.4M, based on as-reported figures from SEC (XBRL) filings.

What is Champions Oncology, Inc.'s Price / Sales?

Champions Oncology, Inc.'s Price / Sales is 1.1×, based on as-reported figures from SEC (XBRL) filings.

What is Champions Oncology, Inc.'s EV / Revenue?

Champions Oncology, Inc.'s EV / Revenue is 1.0×, based on as-reported figures from SEC (XBRL) filings.

What is Champions Oncology, Inc.'s EV / EBITDA?

Champions Oncology, Inc.'s EV / EBITDA is 185.5×, based on as-reported figures from SEC (XBRL) filings.

What is Champions Oncology, Inc.'s Revenue (TTM)?

Champions Oncology, Inc.'s Revenue (TTM) is $60.7M, based on as-reported figures from SEC (XBRL) filings.

What is Champions Oncology, Inc.'s Net Income (TTM)?

Champions Oncology, Inc.'s Net Income (TTM) is -$1.1M, based on as-reported figures from SEC (XBRL) filings.

What is Champions Oncology, Inc.'s EBITDA?

Champions Oncology, Inc.'s EBITDA is $334.0K, based on as-reported figures from SEC (XBRL) filings.

What is Champions Oncology, Inc.'s Diluted EPS (TTM)?

Champions Oncology, Inc.'s Diluted EPS (TTM) is -0.08, based on as-reported figures from SEC (XBRL) filings.

What is Champions Oncology, Inc.'s EBITDA Margin?

Champions Oncology, Inc.'s EBITDA Margin is 0.6%, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Champions Oncology, Inc.

XNAS · usd

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG001S5YHT9

4.72▼ 0.04 (-0.84%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E: —
Price / Sales
EV / Revenue
EV / EBITDA

Financial Highlights

Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt

Trading Information

Previous Close: 4.76
Day's Range: 4.64 – 4.78
52-Week Range: 4.59 – 8.31
Volume: 3,676
Avg Volume: 11.4K

Share Statistics

Shares Outstanding
Employees: 306
Exchange: XNAS
Listed: 1994-10-31

Share count as of September 9, 2026

Champions Oncology, Inc. (CSBR) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about Champions Oncology, Inc. (CSBR)

What is Champions Oncology, Inc.'s Market Cap?: Champions Oncology, Inc.'s Market Cap is $65.7M, based on as-reported figures from SEC (XBRL) filings.
What is Champions Oncology, Inc.'s Enterprise Value?: Champions Oncology, Inc.'s Enterprise Value is $61.4M, based on as-reported figures from SEC (XBRL) filings.
What is Champions Oncology, Inc.'s Price / Sales?: Champions Oncology, Inc.'s Price / Sales is 1.1×, based on as-reported figures from SEC (XBRL) filings.
What is Champions Oncology, Inc.'s EV / Revenue?: Champions Oncology, Inc.'s EV / Revenue is 1.0×, based on as-reported figures from SEC (XBRL) filings.
What is Champions Oncology, Inc.'s EV / EBITDA?: Champions Oncology, Inc.'s EV / EBITDA is 185.5×, based on as-reported figures from SEC (XBRL) filings.
What is Champions Oncology, Inc.'s Revenue (TTM)?: Champions Oncology, Inc.'s Revenue (TTM) is $60.7M, based on as-reported figures from SEC (XBRL) filings.
What is Champions Oncology, Inc.'s Net Income (TTM)?: Champions Oncology, Inc.'s Net Income (TTM) is -$1.1M, based on as-reported figures from SEC (XBRL) filings.
What is Champions Oncology, Inc.'s EBITDA?: Champions Oncology, Inc.'s EBITDA is $334.0K, based on as-reported figures from SEC (XBRL) filings.
What is Champions Oncology, Inc.'s Diluted EPS (TTM)?: Champions Oncology, Inc.'s Diluted EPS (TTM) is -0.08, based on as-reported figures from SEC (XBRL) filings.
What is Champions Oncology, Inc.'s EBITDA Margin?: Champions Oncology, Inc.'s EBITDA Margin is 0.6%, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · CSBRAs-filed SEC (XBRL) data